Follow
A Birkenfeld
A Birkenfeld
Unknown affiliation
Verified email at med.uni-tuebingen.de
Title
Cited by
Cited by
Year
Cardiovascular and renal outcomes with empagliflozin in heart failure
M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ...
New England Journal of Medicine 383 (15), 1413-1424, 2020
37542020
Empagliflozin in heart failure with a preserved ejection fraction
SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ...
New England Journal of Medicine 385 (16), 1451-1461, 2021
27612021
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction
SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ...
New England Journal of Medicine 381 (17), 1609-1620, 2019
17702019
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, P Rossing, P Kolkhof, ...
New England journal of medicine 383 (23), 2219-2229, 2020
14912020
Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
M Husain, AL Birkenfeld, M Donsmark, K Dungan, FG Eliaschewitz, ...
New England Journal of Medicine 381 (9), 841-851, 2019
13332019
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13162018
Practical recommendations for the management of diabetes in patients with COVID-19
SR Bornstein, F Rubino, K Khunti, G Mingrone, D Hopkins, AL Birkenfeld, ...
The lancet Diabetes & endocrinology 8 (6), 546-550, 2020
10492020
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes
AL Birkenfeld, GI Shulman
Hepatology 59 (2), 713-723, 2014
8292014
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
B Pitt, G Filippatos, R Agarwal, SD Anker, GL Bakris, P Rossing, A Joseph, ...
New England Journal of Medicine 385 (24), 2252-2263, 2021
7882021
Obesity and impaired metabolic health in patients with COVID-19
N Stefan, AL Birkenfeld, MB Schulze, DS Ludwig
Nature Reviews Endocrinology 16 (7), 341-342, 2020
7052020
Safety and efficacy of bempedoic acid to reduce LDL cholesterol
KK Ray, HE Bays, AL Catapano, ND Lalwani, LAT Bloedon, LR Sterling, ...
New England Journal of Medicine 380 (11), 1022-1032, 2019
6612019
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled …
PM O'Neil, AL Birkenfeld, B McGowan, O Mosenzon, SD Pedersen, ...
The Lancet 392 (10148), 637-649, 2018
5832018
Global pandemics interconnected—obesity, impaired metabolic health and COVID-19
N Stefan, AL Birkenfeld, MB Schulze
Nature Reviews Endocrinology 17 (3), 135-149, 2021
4222021
Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects
S Haufe, S Engeli, P Kast, J Böhnke, W Utz, V Haas, M Hermsdorf, ...
Hepatology 53 (5), 1504-1514, 2011
3582011
Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance
HY Lee, CS Choi, AL Birkenfeld, TC Alves, FR Jornayvaz, MJ Jurczak, ...
Cell metabolism 12 (6), 668-674, 2010
3472010
Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 …
J Rosenstock, D Allison, AL Birkenfeld, TM Blicher, S Deenadayalan, ...
Jama 321 (15), 1466-1480, 2019
3192019
Bempedoic acid and cardiovascular outcomes in statin-intolerant patients
SE Nissen, AM Lincoff, D Brennan, KK Ray, D Mason, JJP Kastelein, ...
New England Journal of Medicine 388 (15), 1353-1364, 2023
3112023
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial
C Mathieu, P Dandona, P Gillard, P Senior, C Hasslacher, E Araki, M Lind, ...
Diabetes care 41 (9), 1938-1946, 2018
2522018
A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
FR Jornayvaz, MJ Jurczak, HY Lee, AL Birkenfeld, DW Frederick, ...
American Journal of Physiology-Endocrinology and Metabolism 299 (5), E808-E815, 2010
2432010
SGLT2 deletion improves glucose homeostasis and preserves pancreatic β-cell function
MJ Jurczak, HY Lee, AL Birkenfeld, FR Jornayvaz, DW Frederick, ...
Diabetes 60 (3), 890-898, 2011
2402011
The system can't perform the operation now. Try again later.
Articles 1–20